Friday, April 19, 2024
HomeRheumatologyRheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA)

Practice Essentials

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease whose hallmark feature is a persistent symmetric polyarthritis (synovitis) that affects the hands and feet (see the image below). Any joint lined by a synovial membrane may be involved, however, and extra-articular involvement of organs such as the skin, heart, lungs, and eyes can be significant. RA is theorized to develop when a genetically susceptible individual experiences an external trigger (eg, cigarette smoking, infection, or trauma) that triggers an autoimmune reaction. 

Rheumatoid arthritis. Rheumatoid changes in the ha

Rheumatoid arthritis. Rheumatoid changes in the hand. Photograph by David Effron MD, FACEP.

View Media Gallery

 

See Rheumatoid Arthritis: In and Out of the Joint, a Critical Images slideshow, to help identify the distinguishing features of RA as well as the signs of extra-articular manifestations of this disfiguring disease.

Signs and symptoms of rheumatoid arthritis

In most patients with RA, onset is insidious, often beginning with fever, malaise, arthralgias, and weakness before progressing to joint inflammation and swelling.

Signs and symptoms of RA may include the following:

Persistent symmetric polyarthritis (synovitis) of hands and feet (hallmark feature)

Progressive articular deterioration

Extra-articular involvement

Difficulty performing activities of daily living (ADLs)

Constitutional symptoms

The physical examination should address the following:

Upper extremities (metacarpophalangeal joints, wrists, elbows, shoulders)

Lower extremities (ankles, feet, knees, hips)

Cervical spine

During the physical examination, it is important to assess the following:

Stiffness

Tenderness

Pain on motion

Swelling

Deformity

Limitation of motion

Extra-articular manifestations

Rheumatoid nodules

Guidelines for evaluation

2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria

2012 ACR disease activity measures

2011 ACR/EULAR definitions of remission

See Presentation for more detail.

Diagnosis

No test results are pathognomonic; instead, the diagnosis is made by using a combination of clinical, laboratory, and imaging features. Potentially useful laboratory studies in suspected RA include the following:

Erythrocyte sedimentation rate

C-reactive protein level

Complete blood count

Rheumatoid factor assay

Antinuclear antibody assay

Anti−cyclic citrullinated peptide and anti−mutated citrullinated vimentin assays

Potentially useful imaging modalities include the following:

Radiography (first choice): Hands, wrists, knees, feet, elbows, shoulders, hips, cervical spine, and other joints as indicated

Magnetic resonance imaging: Primarily cervical spine

Ultrasonography of joints: Joints, as well as tendon sheaths, changes and degree of vascularization of the synovial membrane, and even erosions

Joint aspiration and analysis of synovial fluid may be considered, including the following:

Gram stain

Cell count

Culture

Assessment of overall appearance

See Workup for more detail.

Management of rheumatoid arthritis

Nonpharmacologic, nonsurgical therapies include the following:

Heat and cold therapies

Orthotics and splints

Therapeutic exercise

Occupational therapy

Adaptive equipment

Joint-protection education

Energy-conservation education

Guidelines for pharmacologic therapy

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2013 EULAR management guidelines

2012 Agency for Healthcare Research and Quality (AHRQ) recommendations

Nonbiologic disease-modifying antirheumatic drugs (DMARDS) include the following:

Hydroxychloroquine

Azathioprine

Sulfasalazine

Methotrexate

Leflunomide

Cyclosporine

Gold salts

D-penicillamine

Minocycline

Biologic tumor necrosis factor (TNF)–inhibiting DMARDs include the following:

Etanercept

Infliximab

Adalimumab

Certolizumab

Golimumab

Biologic non-TNF DMARDs include the following:

Rituximab

Anakinra

Abatacept

Tocilizumab

Sarilumab

Tofacitinib

Baricitinib

Upadacitinib

Other drugs used therapeutically include the following:

Corticosteroids

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Analgesics

Surgical treatments include the following:

Synovectomy

Tenosynovectomy

Tendon realignment

Reconstructive surgery or arthroplasty

Arthrodesis

See Treatment and Medication for more detail.

RELATED ARTICLES

Costochondritis

Fibromyalgia

- Advertisment -

Most Popular